HIV Drug Discovery and Research

The most advanced HIV treatments seeks to inhibit the virus’ ability to replicate its RNA and produce more copies of itself.  HIV protease (an enzyme that cleaves and processes viral precursor proteins letting virion maturation). Treatment regimens containing combinations of reverse transcriptase and protease inhibitors, very often known as Highly Active Antiretroviral Therapy (HAART), it revolutionized the treatment of people with HIV by markedly reducing viral load and decreasing the incidence of AIDS-associated opportunistic infections. Many patients receiving HAART nevertheless experience metabolic abnormalities and drug toxicities, have difficulty adhering to the complex drug regimens, and grow strains of HIV resistant to therapy.

 

  • Stopping the replication of HIV
  • Shock and kill
  • Immunotherapy
  • Gene therapy
  • HIV/AIDS, STDs & STIs – testing
  • Antibody Screening Tests
  • RNA Test
  • In-Home Test Kits

Related Conference of HIV Drug Discovery and Research

September 22-23, 2025

11th International Conference on Infectious and Rare Diseases

Vancouver, Canada
December 11-12, 2025

8th Annual Congress on Bacterial, Viral and Infectious Diseases

Prague, Czech Republic
December 15-16, 2025

7th Global Experts Meeting on Infectious Diseases

Barcelona, Spain
December 17-18, 2025

17th Global Conference on Nephrology and Infectious Diseases

Amsterdam, Netherlands
May 18-19, 2026

15th World Congress on Rare Diseases and Orphan Drugs

Prague, Czech Republic

HIV Drug Discovery and Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in